United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63187-909_563dace5-c1ab-46ff-b3f9-774fe2a62ca5
Product NDC
63187-909
Form
CAPSULE
Composition / generic term
GABAPENTIN
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20160629
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 400 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (63187-909-00) · 63187-909-00
  • 30 CAPSULE in 1 BOTTLE (63187-909-30) · 63187-909-30
  • 60 CAPSULE in 1 BOTTLE (63187-909-60) · 63187-909-60
  • 120 CAPSULE in 1 BOTTLE (63187-909-72) · 63187-909-72
  • 90 CAPSULE in 1 BOTTLE (63187-909-90) · 63187-909-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →